Guelph, ON
January 17, 2022, Zentek Ltd. (“ZEN” or the “Company”) (TSX-V:ZEN and OTC:ZENYF), an IP development and commercialization company focused on next-gen healthcare solutions, announces that Chief Executive Officer Greg Fenton will present at the Sidoti & Company Virtual Small Cap Conference being held from January 19 – 20, 2022.
Mr. Fenton will deliver his corporate presentation on Thursday, January 20, 2022, at 9:15 AM ET, and can be accessed live:
https://sidoti.zoom.us/webinar/register/WN_w9qcEwfQTym18vvLVVVyiQ
Mr. Fenton will also be available for one-on-one meetings throughout the conference. https://www.sidoti.com/events
About Zentek Ltd.
Zentek is a nanotechnology company developing and commercializing next-gen healthcare solutions in the areas of prevention, detection and treatment. Zentek is currently focused on commercializing ZENGuard™, a patent-pending coating shown to have 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as products against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed aptamer-based rapid pathogen detection technology.
For further information:
Matt Blazei
Tel: (212) 655-0924
Email: mattb@coreir.com
|
|
|
